# iSTAR Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/istar-medical

- Industry: Medical Devices & Equipment
- Headquarters: Wavre, Belgium
- Website: www.istar-medical.com
- Total disclosed funding: $36M
- Latest round: Series C (Aug 22, 2019)
- Investors on record: 11

## About

Based in Belgium, and founded in 2010, iSTAR Medical, operates as a developer of medical devices used for providing various eye care solutions to patients. In September 2019, iSTAR Medical SA raised EUR 40.1 million in series C funding co-led by Gimv and EQT Life Sciences, with participation from BNP Paribas Fortis Private Equity and Earlybird Venture Capital. In July 2022, Abbvie agreed to acquire iSTAR Medical SA for USD 60 million. As of 2024, the company is led by Chief Executive Officer (CEO), Michel Vanbrabant.

iSTAR Medical offers various healthcare solutions that include devices like the minimally invasive glaucoma surgery (MIGS) device used for the treatment of eyes with open-angle glaucoma and helping in the reduction of intraocular pressure (IOP). The company’s product portfolio includes STARflo, a micro-porous drainage system that increases the eye's natural uveoscleral outflow, and MINIject, an ab interno MIGS device that enhances the eye's aqueous humour outflow.

## Funding rounds

- Series C, Aug 22, 2019, $19M — Capricorn Partners, EQT Life Sciences, Gimv, Earlybird, BNP Paribas Asset Management - Fund of funds, Société Régionale d'Investissement de Wallonie, SFPI-FPIM
- Series B, May 12, 2015, $11M — Capricorn Partners, Demea Invest, Société Régionale d'Investissement de Wallonie, SFPI-FPIM, Financière Spin-Off Luxembourgeoise, Chagral Invest, Preface
- Series A, Nov 28, 2013, $5.5M — Capricorn Partners, Société Régionale d'Investissement de Wallonie, Financière Spin-Off Luxembourgeoise, Preface

## Investors

- Capricorn Partners (https://capitalatlas.ai/funds/capricorn-partners) — Series A, Series B, Series C
- Société Régionale d'Investissement de Wallonie — Series A, Series B, Series C
- Financière Spin-Off Luxembourgeoise — Series A, Series B
- Preface — Series A, Series B
- Demea Invest (https://capitalatlas.ai/funds/demea-invest) — Series B
- SFPI-FPIM — Series B, Series C
- Chagral Invest — Series B
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series C
- Gimv (https://capitalatlas.ai/funds/gimv) — Series C
- Earlybird (https://capitalatlas.ai/funds/earlybird) — Series C
- BNP Paribas Asset Management - Fund of funds (https://capitalatlas.ai/funds/bnp-paribas-asset-management-fund-of-funds) — Series C